Metabolic syndrome components are associated with DNA hypomethylation

Obesity Research and Clinical Practice

Volumn 7, Issue 2, 2013, Pages

  Luttmer, Roosmarijn ^a   Spijkerman, Annemieke M ^b   Kok, Robert M ^c   Jakobs, Carel ^c   Blom, Henk J ^c   Serne, Erik H ^c   Dekker, Jacqueline M ^a   Smulders, Yvo M ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

DNA methylation; Epigenetics; Fasting plasma glucose; Glucose metabolism; High density lipoprotein cholesterol; Metabolic syndrome; Type 2 diabetes mellitus

Indexed keywords

CYTOSINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA METHYLATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LEUKOCYTE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; FASTING; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84875222298     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2012.06.001     Document Type: Article

References (52)

1. J.M. Dekker, C. Girman, T. Rhodes, G. Nijpels, C.D. Stehouwer, and L.M. Bouter Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study Circulation 112 2005 666 673
2. Anonymous Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
3. R.H. Eckel, S.M. Grundy, and P.Z. Zimmet The metabolic syndrome Lancet 365 2005 1415 1428
4. E.S. Ford Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28 2005 1769 1778
5. S. Inchiostro, G.P. Fadini, S.V. de Kreutzenberg, N. Citroni, and A. Avogaro Is the metabolic syndrome a cardiovascular risk factor beyond its specific components? J Am Coll Cardiol 49 2007 2465 2466
6. R. Castro, I. Rivera, E.A. Struys, E.E. Jansen, P. Ravasco, and M.E. Camilo Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease Clin Chem 49 2003 1292 1296
7. C. Dong, W. Yoon, and P.J. Goldschmidt-Clermont DNA methylation and atherosclerosis J Nutr 132 2002 2406S 2409S
8. M.O. Hiltunen, M.P. Turunen, T.P. Hakkinen, J. Rutanen, J. Hedman, and K. Makinen DNA hypomethylation and methyltransferase expression in atherosclerotic lesions Vasc Med 7 2002 5 11
9. M.O. Laukkanen, S. Mannermaa, M.O. Hiltunen, S. Aittomaki, K. Airenne, and J. Janne Local hypomethylation in atherosclerosis found in rabbit ec-sod gene Arterioscler Thromb Vasc Biol 19 1999 2171 2178
10. P. Sharma, J. Kumar, G. Garg, A. Kumar, A. Patowary, and G. Karthikeyan Detection of altered global DNA methylation in coronary artery disease patients DNA Cell Biol 27 2008 357 365
11. A.S. Wilson, B.E. Power, and P.L. Molloy DNA hypomethylation and human diseases Biochim Biophys Acta 1775 2007 138 162
12. J. Yideng, Z. Jianzhong, H. Ying, S. Juan, Z. Jinge, and W. Shenglan Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs DNA Cell Biol 26 2007 603 611
13. S. Zaina, M.W. Lindholm, and G. Lund Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? J Nutr 135 2005 5 8
14. M.T. Bedford, and S.G. Clarke Protein arginine methylation in mammals: who, what, and why Mol Cell 33 2009 1 13
15. G. Egger, G. Liang, A. Aparicio, and P.A. Jones Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
16. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2002 2015 2022
17. E.K. Hoogeveen, P.J. Kostense, P.J. Beks, A.J. Mackaay, C. Jakobs, and L.M. Bouter Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study Arterioscler Thromb Vasc Biol 18 1998 133 138
18. E.K. Hoogeveen, P.J. Kostense, C. Jakobs, J.M. Dekker, G. Nijpels, and R.J. Heine Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study Circulation 101 2000 1506 1511
19. S.G. Davey, and S. Ebrahim Folate supplementation and cardiovascular disease Lancet 366 2005 1679 1681
20. J. Loscalzo Homocysteine trials-clear outcomes for complex reasons N Engl J Med 354 2006 1629 1632
21. D.S. Wald, N.J. Wald, J.K. Morris, and M. Law Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence BMJ 333 2006 1114 1117
22. R. Castro, I. Rivera, H.J. Blom, C. Jakobs, and D.A.I. Tavares Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview J Inherit Metab Dis 29 2006 3 20
23. D. Ingrosso, A. Cimmino, A.F. Perna, L. Masella, N.G. De Santo, and M.L. De Bonis Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia Lancet 361 2003 1693 1699
24. M.S. Jamaluddin, X. Yang, and H. Wang Hyperhomocysteinemia, DNA methylation and vascular disease Clin Chem Lab Med 45 2007 1660 1666
25. M.E. Lee, and H. Wang Homocysteine and hypomethylation. A novel link to vascular disease Trends Cardiovasc Med 9 1999 49 54
26. R. 26.Barres, and J.R. Zierath DNA methylation in metabolic disorders Am J Clin Nutr 93 suppl 2011 897S 900S
27. J.M. Mooy, P.A. Grootenhuis, H. de Vries, H.A. Valkenburg, L.M. Bouter, and P.J. Kostense Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study Diabetes Care 18 1995 1270 1273
28. A.M. Spijkerman, M.C. Adriaanse, J.M. Dekker, G. Nijpels, C.D. Stehouwer, and L.M. Bouter Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile Diabetes Care 25 2002 1784 1789
29. R.M. Henry, I. Ferreira, P.J. Kostense, J.M. Dekker, G. Nijpels, and R.J. Heine Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study Atherosclerosis 174 2004 49 56
30. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
31. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
32. R.M. Kok, D.E. Smith, R. Barto, A.M. Spijkerman, T. Teerlink, and H.J. Gellekink Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: analytical technique, reference values and determinants in healthy subjects Clin Chem Lab Med 45 2007 903 911
33. M.H. Jiang, J. Fei, M.S. Lan, Z.P. Lu, M. Liu, and W.W. Fan Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential Diabetologia 51 2008 1525 1533
34. C. Ling, G.S. Del, R. Lupi, T. Rönn, C. Granhall, and H. Luthman Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion Diabetologia 2008
35. D.S. Longnecker Abnormal methyl metabolism in pancreatic toxicity and diabetes J Nutr 132 2002 2373S 2376S
36. T. Rönn, P. Poulsen, O. Hansson, J. Holmkvist, P. Almgren, and P. Nilsson Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle Diabetologia 51 2008 1159 1168
37. R.A. Waterland, M. Travisano, K.G. Tahiliani, M.T. Rached, and S. Mirza Methyl donor supplementation prevents transgenerational amplification of obesity Int J Obes (Lond) 32 2008 1373 1379
38. A. Festa, R. D'Agostino Jr., G. Howard, L. Mykkanen, R.P. Tracy, and S.M. Haffner Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 2000 42 47
39. R. Castro, I. Rivera, C. Martins, E.A. Struys, E.E. Jansen, and N. Clode Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC J Mol Med 83 2005 831 836
40. S. Friso, S.W. Choi, D. Girelli, J.B. Mason, G.G. Dolnikowski, and P.J. Bagley A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status Proc Natl Acad Sci USA 99 2002 5606 5611
41. J. Yideng, L. Zhihong, X. Jiantuan, C. Jun, L. Guizhong, and W. Shuren Homocysteine-mediated PPARalpha,gamma DNA methylation and its potential pathogenic mechanism in monocytes DNA Cell Biol 27 2008 143 150
42. A. Becker, R.M. Henry, P.J. Kostense, C. Jakobs, T. Teerlink, and S. Zweegman Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals. The Hoorn Study Atherosclerosis 169 2003 323 330
43. D.J. Barker The developmental origins of insulin resistance Horm Res 64 Suppl. 3 2005 2 7
44. S.U. Devaskar, and M. Thamotharan Metabolic programming in the pathogenesis of insulin resistance Rev Endocr Metab Disord 8 2007 105 113
45. C. Junien, and P. Nathanielsz Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes Obes Rev 8 2007 487 502
46. R.A. Simmons Developmental origins of beta-cell failure in type 2 diabetes: the role of epigenetic mechanisms Pediatr Res 61 2007 64R 67R
47. G.C. Burdge, J. Slater-Jefferies, C. Torrens, E.S. Phillips, M.A. Hanson, and K.A. Lillycrop Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations Br J Nutr 97 2007 435 439
48. K.A. Lillycrop, J.L. Slater-Jefferies, M.A. Hanson, K.M. Godfrey, A.A. Jackson, and G.C. Burdge Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications Br J Nutr 97 2007 1064 1073
49. K.A. Lillycrop, E.S. Phillips, C. Torrens, M.A. Hanson, A.A. Jackson, and G.C. Burdge Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPARalpha promoter of the offspring Br J Nutr 2008 1 5
50. J.H. Park, D.A. Stoffers, R.D. Nicholls, and R.A. Simmons Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1 J Clin Invest 118 2008 2316 2324
51. C.S. Yajnik, S.S. Deshpande, A.A. Jackson, H. Refsum, S. Rao, and D.J. Fisher Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study Diabetologia 51 2008 29 38
52. L.M. Villeneuve, M.A. Reddy, and R. Natarajan Epigenetics: deciphering its role in diabetes and its chronic complications Clin Exp Pharmacol Physiol 38 2011 401 409